Zylox-Tonbridge Medical Technology Co., Ltd. 13D and 13G filings for Avinger, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-03 06:26 am Purchase | 2024-03-05 | 13D | Avinger, Inc. AVGR | Zylox-Tonbridge Medical Technology Co., Ltd. | 1,981,655 49.900% | 1,559,439 (+369.35%) | Filing |
| 2024-03-14 9:37 pm Purchase | 2024-03-05 | 13D | Avinger, Inc. AVGR | Zylox-Tonbridge Medical Technology Co., Ltd. | 422,216 19.900% | 422,216 (New Position) | Filing |